Acme United (ACU) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 May, 2026Strategic positioning and growth
Focus on innovation, diversified customer base, and 15 years of consecutive sales growth from ongoing operations.
Growth driven by successful acquisitions, investment in domestic production, and international sourcing.
Leveraging shared technologies and cross-brand collaboration to drive value across the platform.
Recent acquisition of My Medic, a leading supplier of tactical and trauma products, for $18.7 million, with $19 million in 2025 revenues.
International footprint includes facilities in the US, Canada, Europe, and China.
Financial performance
Net sales grew from $73.3M in 2011 to $196.5M in 2025, despite divesting hunting & fishing lines in 2023.
EBITDA increased from $5.3M in 2011 to $21.0M in 2025, supporting strong cash flow.
Net income rose from $2.8M in 2011 to $10.2M in 2025, reflecting consistent profitability.
Earnings per share reached $2.57 in 2025, up from $0.91 in 2011.
Quarterly dividend increased to $0.16 per share in June 2025, with a history of consistent growth.
Market opportunities and product innovation
North American first aid market generated $2.1B in 2023, representing 45.5% of the global market, with a projected CAGR of 4.4% through 2030.
Growth drivers include workplace safety regulations, rising injury rates, and increased consumer focus on emergency preparedness.
Smart Compliance cabinets use patented bar code scanning for efficient replenishment and compliance.
Launch of all-in-one AED + First Aid Emergency Response Bag in Q1 2026, designed for faster access and compliance.
Expansion in lens care, proprietary cutting tools, craft, and kitchen product categories, leveraging patented technologies and strong retail partnerships.
Latest events from Acme United
- First aid and safety drive growth, targeting $300M revenue in three years with global expansion.ACU
Sidoti Micro-Cap Virtual Conference20 May 2026 - Q1 2026 sales up 14%, but net income down 40% as higher costs and tariffs offset gains.ACU
Q1 20266 May 2026 - All proposals, including board elections and stock plan amendments, were approved by majority vote.ACU
AGM 202628 Apr 2026 - Shareholders will vote on director elections, stock option plan expansion, executive pay, and auditor ratification.ACU
Proxy filing27 Mar 2026 - Record 2025 results and Q4 growth, with acquisitions and investments fueling future expansion.ACU
Q4 202527 Feb 2026 - Q2 net income up 29% with margin gains and Elite First Aid acquisition completed.ACU
Q2 20243 Feb 2026 - Q3 net sales fell 4% but net income rose 3% as Europe and product lines outperformed.ACU
Q3 202419 Jan 2026 - Record sales, product innovation, and supply chain shifts drive growth and margin expansion.ACU
17th Annual LD Micro Main Event Conference18 Jan 2026 - Revenue growth, innovation, and acquisitions position the firm for $300M in sales by 2027.ACU
2024 Southwest IDEAS Conference12 Jan 2026